scispace - formally typeset
E

Edward G. Lakatta

Researcher at National Institutes of Health

Publications -  902
Citations -  95504

Edward G. Lakatta is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Blood pressure & Population. The author has an hindex of 146, co-authored 858 publications receiving 88637 citations. Previous affiliations of Edward G. Lakatta include University of Pittsburgh & University College London.

Papers
More filters
Journal ArticleDOI

Age-associated alterations in calcium current and its modulation in cardiac myocytes

TL;DR: Age-dependent changes in ICa,L and its modulations are similar to those observed in the enlarged myocytes of the hypertrophied and failing heart and may be an important cause of the age-related decrease in cardiac reserve function.
Journal ArticleDOI

No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque

TL;DR: The data do not support the idea that treating subclinical disorders might help to prevent arterial remodelling or carotid atherosclerosis, and Thyroid hormone is not associated with increased IMT or with the presence ofCarotid artery plaque.
Journal ArticleDOI

Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study

TL;DR: This work investigated the relationship between thyroid function and carotid‐femoral PWV, as an index of arterial stiffness, and found that thyroid dysfunction may accelerate atherosclerosis.
Journal ArticleDOI

PDGF Receptor-to-Nucleus Signaling of p91 (STAT1α) Transcription Factor in Rat Smooth Muscle Cells

TL;DR: It is demonstrated that PDGF-stimulated smooth muscle cells activate the STAT (signal transducers and activators of transcription) family of proteins in addition to other signaling pathways (e.g., RAS-RAF-MAP Kinase) and hypothesize that signal transduction by p91 plays an important role in VSMC, especially after injury with the release of growth factors such as PDGF.
Journal ArticleDOI

Enantiomeric dissection of the effects of the inotropic agent, EMD 53998, in single cardiac myocytes.

TL;DR: In intact cells the positive inotropic effect of EMD 53998 is due to specific properties of its enantiomers: the (-)-enantiomer has adenosine 3',5'-cyclic monophosphate-like effects (increase in amplitude and reduction of [Ca2+]i transient and contraction durations), whereas the (+)- enantiomer enhances the myofilament- Ca2+ interaction.